// startup autopsy
Sloning BioTechnology
Gene synthesis pioneer absorbed before reaching commercial scale
marketfitAcqui-hire
Fatal mistake: Focused on building proprietary technology without securing enough commercial partnerships to justify independent growth.
Key Events Timeline
FOUNDING
Sloning BioTechnology founded in Germany to develop proprietary gene synthesis platform.
FUNDING
Raised early-stage funding to advance gene synthesis technology platform.
FUNDING
Secured final round of $10.69M to commercialize technology, last known funding event.
SHUTDOWN
Acquired by strategic buyer; independent operations ceased as company could not scale commercially.